Acuvance, a healthcare advisory platform backed by Trinity Hunt Partners, acquired ROI Healthcare Solutions on January 20, 2026. The acquisition aims to bolster Acuvance's capability in supporting healthcare organizations through complex ERP transitions.

AcquirerAcuvance (US)
TargetROI Healthcare Solutions (US)
Deal valueUndisclosed
Stake acquired100.0%
Type of dealAcquisition
Date closedJanuary 20, 2026
Buy-side financial advisor(s)CrossBorder
Sell-side financial advisor(s)CrossBorder
Legal advisors (buy-side)Kirkland & Ellis
Legal advisors (sell-side)Barnes & Thornburg, Adviso Partners, Nixon Peabody

Deal mechanics

Crosstree served as the exclusive financial advisor to both ROI Healthcare Solutions and Acuvance in this transaction. Kirkland & Ellis acted for the buyer while Barnes & Thornburg, Adviso Partners, and Nixon Peabody advised the seller.

Strategic rationale

Acuvance's acquisition of ROI Healthcare Solutions enhances its offerings by integrating ROI’s expertise in ERP implementation and optimization. This move aligns with growing industry forecasts estimating the U.S. healthcare ERP market to expand from approximately $2.2 billion today to nearly $3.8 billion over the next decade.

Financial context

The deal value was not disclosed, reflecting a common practice in strategic acquisitions within the healthcare technology sector. ROI Healthcare Solutions has maintained formal partnerships with Infor, Workday, and Oracle, leveraging these relationships to support its clients' ERP needs.